The decision making process that underlies ovarian hormone therapy (HT)
is fallible. Thus, the decision for women to go on HT remains
controversial. At a time when confusion still permeates the decision
making with regard to HT, this book bridges diverse features that
surround the decision making concerning HT. The book is written for both
specialists and generalists in the field.